Cell Reports
(Oct 2014)
Glutamate Acts as a Key Signal Linking Glucose Metabolism to Incretin/cAMP Action to Amplify Insulin Secretion
Ghupurjan Gheni,
Masahito Ogura,
Masahiro Iwasaki,
Norihide Yokoi,
Kohtaro Minami,
Yasumune Nakayama,
Kazuo Harada,
Benoit Hastoy,
Xichen Wu,
Harumi Takahashi,
Kazushi Kimura,
Toshiya Matsubara,
Ritsuko Hoshikawa,
Naoya Hatano,
Kenji Sugawara,
Tadao Shibasaki,
Nobuya Inagaki,
Takeshi Bamba,
Akira Mizoguchi,
Eiichiro Fukusaki,
Patrik Rorsman,
Susumu Seino
Affiliations
Ghupurjan Gheni
Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Chuo-ku, Kobe 650-0017, Japan
Masahito Ogura
Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Chuo-ku, Kobe 650-0017, Japan
Masahiro Iwasaki
Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Chuo-ku, Kobe 650-0017, Japan
Norihide Yokoi
Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Chuo-ku, Kobe 650-0017, Japan
Kohtaro Minami
Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Chuo-ku, Kobe 650-0017, Japan
Yasumune Nakayama
Department of Biotechnology, Graduate School of Engineering, Osaka University, Yamadaoka, Suita 565-0871, Japan
Kazuo Harada
Applied Environmental Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Yamadaoka, Suita 565-0871, Japan
Benoit Hastoy
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK
Xichen Wu
Alberta Diabetes Institute, University of Alberta, Faculty of Medicine & Dentistry, Edmonton, AB T6G 2E1, Canada
Harumi Takahashi
Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Chuo-ku, Kobe 650-0017, Japan
Kazushi Kimura
Department of Neural Regeneration and Cell Communication, Mie University Graduate School of Medicine, Edobashi, Tsu 514-8507, Japan
Toshiya Matsubara
Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Chuo-ku, Kobe 650-0017, Japan
Ritsuko Hoshikawa
Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Chuo-ku, Kobe 650-0017, Japan
Naoya Hatano
The Integrated Center for Mass Spectrometry, Kobe University Graduate School of Medicine, Chuo-ku, Kobe 650-0017, Japan
Kenji Sugawara
Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Chuo-ku, Kobe 650-0017, Japan
Tadao Shibasaki
Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Chuo-ku, Kobe 650-0017, Japan
Nobuya Inagaki
Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606–8507, Japan
Takeshi Bamba
Department of Biotechnology, Graduate School of Engineering, Osaka University, Yamadaoka, Suita 565-0871, Japan
Akira Mizoguchi
Department of Neural Regeneration and Cell Communication, Mie University Graduate School of Medicine, Edobashi, Tsu 514-8507, Japan
Eiichiro Fukusaki
Department of Biotechnology, Graduate School of Engineering, Osaka University, Yamadaoka, Suita 565-0871, Japan
Patrik Rorsman
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK
Susumu Seino
Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Chuo-ku, Kobe 650-0017, Japan
DOI
https://doi.org/10.1016/j.celrep.2014.09.030
Journal volume & issue
Vol. 9,
no. 2
pp.
661
– 673
Abstract
Read online
Incretins, hormones released by the gut after meal ingestion, are essential for maintaining systemic glucose homeostasis by stimulating insulin secretion. The effect of incretins on insulin secretion occurs only at elevated glucose concentrations and is mediated by cAMP signaling, but the mechanism linking glucose metabolism and cAMP action in insulin secretion is unknown. We show here, using a metabolomics-based approach, that cytosolic glutamate derived from the malate-aspartate shuttle upon glucose stimulation underlies the stimulatory effect of incretins and that glutamate uptake into insulin granules mediated by cAMP/PKA signaling amplifies insulin release. Glutamate production is diminished in an incretin-unresponsive, insulin-secreting β cell line and pancreatic islets of animal models of human diabetes and obesity. Conversely, a membrane-permeable glutamate precursor restores amplification of insulin secretion in these models. Thus, cytosolic glutamate represents the elusive link between glucose metabolism and cAMP action in incretin-induced insulin secretion.
WeChat QR code
Close